Toxoid Vaccine
Antibody Responses to Natural Rattlesnake Envenomation and a Rattlesnake Toxoid Vaccine in Horses
... the toxoid vaccine may be ...adverse vaccine reactions were noted in the mares, indicating the vaccine is safe to be given to late-gestation ...
6
Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
... diphtheria toxoid containing vaccines (TDCVs), and the risk of local reactions may increase with the number of prior vaccina- tions ...diphtheria toxoid are currently licensed for routine use in adolescents ...
7
A biomimetic nanoparticle-enabled toxoid vaccine against melittin
... complex vaccine against melittin was evaluated both in vitro and in ...perforation toxoid group, which could inspire the development of a broad-spectrum antitoxin vaccine and show potential ...
11
In vivo evaluation of single dose tetanus toxoid vaccine formulation with chitosan microspheres
... From our studies, it was observed that the size of microspheres increased with the decrease in the speed of agitation. The amount of drug loaded was 70-84% by limes ß occulation test. The biodegradable microspheres made ...
6
Immunologic and Epidemiologic Experience of Vaccination With a Monocomponent Pertussis Toxoid Vaccine
... pertussis toxoid (PTox), compounded with diphtheria and tetanus toxoids, was administered to 3450 children according to the Swedish schedule at 3, 5, and 12 months of ...
8
An Evaluation of the Safety and Immunogenicity of a Five-Component Acellular Pertussis, Diphtheria, and Tetanus Toxoid Vaccine (DTaP) When Combined With a Haemophilus influenzaeType b-Tetanus Toxoid Conjugate Vaccine (PRP-T) in Taiwanese Infants
... Local reactions at the DTaP injection site were seen in 43%, 29%, and 25% of participants after the first, second, and third doses, respectively. Only 2% of parents reported local reactions after the fourth dose. Local ...
8
Additional Recommendations for Use of Tetanus Toxoid, Reduced-Content Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap)
... tetanus toxoid, reduced-diphtheria toxoid, and reduced-content acellu- lar pertussis vaccine (Tdap) instead of tetanus and diphtheria toxoid vaccine (Td) for adolescents aged 11 through ...
6
Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
... containing vaccine or a diphtheria toxoid vaccine that does not contain tetanus toxoid, such as MCV4 (which contains diphtheria toxoid as a carrier pro- tein); if a true Arthus reaction ...
16
Pre-Clinical and Clinical Validation of Vaccines Against Hemolytic Uremic Syndrome
... whole-cell vaccine and a toxoid vaccine prepared for Escherichia coli O157:H7 strain using rats as animal models after pre-clinical methods of ...cell vaccine and a toxoid ...
6
Protection against avian necrotic enteritis after immunisation with NetB genetic or formaldehyde toxoids
... NetB toxoid or NetB W262A could be used in subsequent work to devise a vaccine to control ...NetB toxoid, the NetB W262A mutant is easily produced in ...in vaccine prepa- rations to avoid ...
7
Immune response to type III group B streptococcal polysaccharide tetanus toxoid conjugate vaccine
... 100 healthy nonpregnant women between 18 and 40 yr of age were enrolled in one of two studies after giving written informed consent. The studies were approved by the Institutional Review Board for Hu- man Subject ...
8
Neonatal Immunization: Response to Haemophilus influenzae Type b-Tetanus Toxoid Conjugate Vaccine
... Blood samples were taken at 2 days, 4 months, and 14 months (before each Hib vaccination), at 6 months (2 months after the second dose of Hib vaccine), and at 15 months (1 month after th[r] ...
10
Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
... the vaccine was studied in Phase II and Phase III randomized controlled trials ...assess vaccine response, which is defined by either rSBA titers $1:32 in initially seronegative subjects or the development ...
15
Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants
... planned to enroll in another clinical study during the current study period; (2) received or expected to receive immunosuppressive agents; (3) received systemic steroids (equivalent of .2 mg/kg per day prednisone) since ...
12
Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents
... Centennial, CO : I. Melamed; Center for Pediatric Re- search, Norfolk, VA: D. Mitchell; Baylor College of Med- icine and Affiliated Hospitals, Houston, TX: F. Mun˜oz; University Hospital, Stony Brook, NY: S. Nachman; ...
12
Safety and Immunogenicity of a Combined Diphtheria, Tetanus, Pertussis and Haemophilus influenzae Type b Vaccine in Young Infants
... Current US immunization practices require vacci- nation of young infants starting at 2 months of age with both diphtheria and tetanus toxoid and pertussis vaccine (DTP) and Haemophilus i[r] ...
8
Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age
... MCC/Hib vaccine in which both components are conjugated to TT (Menitorix; GSK) followed by PCV7 and MMR vaccine at 13 months of ...MCC/Hib vaccine, PCV7, and MMR vaccine concomitantly (group ...
6
Urushiol (poison ivy) triggered suppressor T cell clone generated from peripheral blood
... restricted. RLB9-7 was WT31 positive, indicating it bears the alpha beta T cell receptor. The clone lacked significant natural killer cell activity and produced only low levels of IL-2 or gamma-interferon upon antigen ...
9
Knowledge and Acceptability about Adult Pertussis Immunization in Korean Women of Childbearing Age
... Purpose: The adult tetanus, reduced diphtheria, and acellular pertussis (Tdap) vac- cine has been introduced in order to provide individual protection and reduce the risk of transmitting pertussis to infants. We assessed ...
8
Safety and immunogenicity of three doses of an eleven valent diphtheria toxoid and tetanus protein – conjugated pneumococcal vaccine in Filipino infants
... study vaccine by the investi- ...three vaccine doses of the 11-PncTD vaccine are summarised in Table ...three vaccine doses, all GMCs of antibodies, except for serotype 14 (p = ...
6